title: Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.
abstract: The search for biomarkers in the management of lung cancer involves the use of multiple platforms to examine changes in gene, protein, and microRNA expression. Multiple studies have been published in an attempt to describe early detection, diagnostic, prognostic, and predictive biomarkers using chiefly tissues and blood elements. Studies are characterized by a lack of commonality of specific biomarkers, and a lack of validated, clinically useful markers. The future of biomarker discovery as a means of tailoring therapy for patients with lung cancer will involve next-generation sequencing along with collaborative efforts to integrate and validate candidate markers.
authors.affiliation: Department of Cardiothoracic Surgery, NYU Langone Medical Center, 530 First Avenue, 9V, New York, NY 10016, USA. Harvey.Pass@nyumc.org
authors.forename: Harvey I
authors.initials: HI
authors.lastname: Pass
authors.forename: David G
authors.initials: DG
authors.lastname: Beer
authors.forename: Sasha
authors.initials: S
authors.lastname: Joseph
authors.forename: Pierre
authors.initials: P
authors.lastname: Massion
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D055088:Early Detection of Cancer; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000235:genetics*; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor